InvestorsHub Logo
Followers 229
Posts 21458
Boards Moderated 2
Alias Born 08/03/2006

Re: mojo joyo post# 3326

Thursday, 09/10/2020 9:13:07 AM

Thursday, September 10, 2020 9:13:07 AM

Post# of 3516
Diffusion Pharmaceuticals Doses First Two Patients with TSC in COVID-19 Clinical Trial
GlobeNewswire
Diffusion Pharmaceuticals Inc.
GlobeNewswireSeptember 10, 2020
Twenty-four patient Phase 1b safety and tolerability study initiated in Romania

CHARLOTTESVILLE, Va., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”) today announced dosing of the first two patients in the Company’s open-label Phase 1b lead-in trial of its novel, oxygen-enhancing therapeutic, trans sodium crocetinate (“TSC”), in 24 hospitalized COVID-19 patients. In addition to evaluating the safety and tolerability of TSC, this trial will collect preliminary data on TSC’s effects on arterial blood oxygenation. The Company believes these pharmacodynamic data will provide proof of concept for TSC in hypoxemic patients, and these data will be used to guide design of the planned follow-on efficacy study.

https://finance.yahoo.com/news/diffusion-pharmaceuticals-doses-first-two-120000585.html


Do your research! Play the TA. All posts are my opinion.
Is fundamental trading dead?

"We hope not." Richard Dennis

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DFFN News